{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T20:58:54Z","timestamp":1774645134364,"version":"3.50.1"},"reference-count":19,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":411,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2000,11,8]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The aim of this retrospective study was to investigate the epidemiology, yield of investigations and proportion of patients who develop systemic lupus erythematosus (SLE) among the subsets of cutaneous lupus erythematosus (LE) in the Singapore Asian population. One hundred and twenty\u2010five patients were diagnosed with cutaneous LE on clinico\u2013pathological correlation, of which 73 had discoid lupus erythematosus (DLE), eight had subacute cutaneous LE (SCLE), 22 had acute LE lesions and the remainder had other less common forms of cutaneous LE. Histology was consistent with LE in 94.4% and suggestive in 4.8%. Direct immunofluorescence was positive in 61% of DLE, 86% of SCLE and 80% of acute LE cases. Antinuclear antibody (ANA) was present in the majority of acute LE (85%) and SCLE (88%) but only in 25% of DLE. Eight patients (11%) presenting with DLE had definite SLE at first presentation and two (2.7%) subsequently several months later. Of these patients, six had only mucocutaneous and serological criteria but two had major organ involvement. Five SCLE patients (63%) fulfilled the criteria for SLE, including two with major organ involvement.<\/jats:p>","DOI":"10.1046\/j.1440-0960.2000.00443.x","type":"journal-article","created":{"date-parts":[[2003,3,10]],"date-time":"2003-03-10T11:26:41Z","timestamp":1047295601000},"page":"229-233","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Epidemiology of cutaneous lupus erythematosus in a tertiary referral centre in Singapore"],"prefix":"10.1111","volume":"41","author":[{"given":"Patricia PL","family":"Ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suat Hoon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ee Tzun","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulip","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1959.01560160040005"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(81)80261-7"},{"key":"e_1_2_5_4_2","doi-asserted-by":"crossref","unstructured":"TanEM CohenAS FriesJFet al.The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum.1982;25: 1271\u20137.","DOI":"10.1002\/art.1780251101"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780220403"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00286136"},{"key":"e_1_2_5_7_2","unstructured":"RowellNR&GoodfieldMJD.The \u2018connective tissue diseases\u2019. In: Champion RH Burton JL Burns DA Breathnach SM (eds).Textbook of Dermatology.6th edn. Oxford: Blackwell Scientific Publication 1998; 2437\u2013576."},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1979.04010090005011"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/archderm.1984.01650390054011","article-title":"Subacute cutaneous lupus erythematosus and discoid lupus erythematosus: Comparative histopathologic findings.","volume":"120","author":"Bangert JL","year":"1984","journal-title":"Arch. Dermatol."},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/archderm.1990.01670250058008","article-title":"Histopathologic comparison of the subsets of lupus erythematosus.","volume":"126","author":"Jerdan MS","year":"1990","journal-title":"Arch. Dermatol."},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archderm.1994.01690010058007","article-title":"Histopathologic findings in cutaneous lupus erythematosus.","volume":"130","author":"Bielsa I","year":"1994","journal-title":"Arch. Dermatol."},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30633-2"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(86)70052-2"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/archderm.1973.01620190039009","article-title":"Action spectra of lupus erythematosus and experimental immunofluorescence.","volume":"107","author":"Cripps DJ","year":"1973","journal-title":"Arch. Dermatol."},{"key":"e_1_2_5_15_2","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archderm.1983.01650360056014","article-title":"Usefulness of direct immunofluorescence in patients with lupus erythematosus.","volume":"119","author":"Dahl MV.","year":"1983","journal-title":"Arch. Dermatol."},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00915389"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archderm.1967.01610030068012","article-title":"The diagnostic value of an antinuclear antibody test in clinical dermatology.","volume":"96","author":"Rowell NR.","year":"1967","journal-title":"Arch. Dermatol."},{"key":"e_1_2_5_18_2","first-page":"278","article-title":"Systemic lupus erythematosus\u2014Initial manifestations and clinical features after 10 years of disease.","volume":"26","author":"Fong KY","year":"1997","journal-title":"Ann. Acad. Med. Singapore"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1971.tb14209.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-5-664"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-0960.2000.00443.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-0960.2000.00443.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T18:40:14Z","timestamp":1698604814000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-0960.2000.00443.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11,8]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,11,8]]}},"alternative-id":["10.1046\/j.1440-0960.2000.00443.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-0960.2000.00443.x","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11,8]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}